Pancreatic Cystadenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Sources

Aliases & Classifications for Pancreatic Cystadenocarcinoma

MalaCards integrated aliases for Pancreatic Cystadenocarcinoma:

Name: Pancreatic Cystadenocarcinoma ¹² ¹⁵

Cystadenocarcinoma of Pancreas ¹² ⁷³

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Endocrine diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:4073

NCIt ⁵⁰ C3874

SNOMED-CT ⁶⁸ 235966007

UMLS ⁷³ C0238337

Sources

Summaries for Pancreatic Cystadenocarcinoma

MalaCards based summary : Pancreatic Cystadenocarcinoma, also known as cystadenocarcinoma of pancreas, is related to pancreatic serous cystadenocarcinoma and sinonasal undifferentiated carcinoma, and has symptoms including abdominal pain, icterus and pruritus. An important gene associated with Pancreatic Cystadenocarcinoma is CPQ (Carboxypeptidase Q), and among its related pathways/superpathways are Folate Metabolism and NRF2 pathway. The drugs Ethanol and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include pancreas, ovary and liver, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Sources

Related Diseases for Pancreatic Cystadenocarcinoma

Diseases related to Pancreatic Cystadenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 132)

#	Related Disease	Score	Top Affiliating Genes
1	pancreatic serous cystadenocarcinoma	11.1
2	sinonasal undifferentiated carcinoma	10.9	MKI67 SYP
3	esophageal neuroendocrine tumor	10.8	CHGA SYP
4	ureter small cell carcinoma	10.8	CHGA SYP
5	urinary bladder small cell neuroendocrine carcinoma	10.8	CHGA SYP
6	ovarian large-cell neuroendocrine carcinoma	10.8	CHGA SYP
7	auditory system cancer	10.8	CHGA SYP
8	adenoma of the pancreas	10.8	CHGA SYP
9	peritoneal serous adenocarcinoma	10.8	CHGA SYP
10	cellular ependymoma	10.8	CHGA SYP
11	gallbladder small cell carcinoma	10.8	CHGA SYP
12	primary hepatic neuroendocrine carcinoma	10.8	CHGA SYP
13	inflammatory mfh	10.8	SERPINA1 SERPINA3
14	small cell carcinoma of the bladder	10.8	CHGA SYP
15	gastrointestinal neuroendocrine tumor	10.8	CHGA SYP
16	adult teratoma	10.8	AFP CHGA
17	pulmonary large cell neuroendocrine carcinoma	10.8	CHGA SYP
18	chordoid meningioma	10.7	CHGA SYP
19	olfactory nerve neoplasm	10.7	CHGA SYP
20	cauda equina neoplasm	10.7	CHGA SYP
21	sclerosing hepatic carcinoma	10.7	AFP CHGA
22	conventional angiosarcoma	10.7	CHGA SYP
23	malignant sertoli cell tumor	10.7	AFP SYP
24	pancreatic somatostatinoma	10.7	CALCA SYP
25	polyembryoma	10.7	AFP SERPINA1
26	pancreatic acinar cell adenocarcinoma	10.7	AFP CHGA
27	secondary hypertrophic osteoarthropathy	10.7	CALCA KRAS
28	nodular ganglioneuroblastoma	10.7	CHGA SYP
29	scrotal carcinoma	10.6	AFP SERPINA3
30	pulmonary sclerosing hemangioma	10.6	CHGA SYP
31	sigmoid neoplasm	10.6	CEACAM5 KRAS
32	malignant fibroxanthoma	10.6	MKI67 SERPINA1 SERPINA3
33	pineocytoma	10.6	CHGA SYP
34	adenosquamous gallbladder carcinoma	10.6	CEACAM5 SERPINA3
35	malignant teratoma	10.6	AFP SYP
36	apocrine adenoma	10.6	CEACAM5 KRAS
37	gastric squamous cell carcinoma	10.6	CHGA SERPINA3 SYP
38	female urethral cancer	10.6	CEACAM5 CHGA
39	mature teratoma	10.6	AFP KRAS
40	endometrial small cell carcinoma	10.6	AFP SYP
41	respiratory system benign neoplasm	10.6	CHGA KRAS SYP
42	pulmonary blastoma	10.6	CHGA KRAS SYP
43	mediastinal cancer	10.5	AFP SYP
44	lung benign neoplasm	10.5	CHGA KRAS SYP
45	mucinous adenofibroma	10.5	CEACAM5 SYP
46	aggressive digital papillary adenocarcinoma	10.5	CEACAM5 KRAS
47	adenoid cystic carcinoma	10.5	KRAS MKI67 SERPINA3
48	subependymoma	10.5	CHGA SYP
49	granulosa cell tumor of the ovary	10.5	CHGA SERPINA1 SYP
50	urachal adenocarcinoma	10.5	AFP CEACAM5

Graphical network of the top 20 diseases related to Pancreatic Cystadenocarcinoma:

Sources

Symptoms & Phenotypes for Pancreatic Cystadenocarcinoma

UMLS symptoms related to Pancreatic Cystadenocarcinoma:

abdominal pain, icterus, pruritus

GenomeRNAi Phenotypes related to Pancreatic Cystadenocarcinoma according to GeneCards Suite gene sharing:

²⁶ (show all 18)

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased shRNA abundance (Z-score < -2)	GR00366-A-1	9.96	TXN
2	Decreased shRNA abundance (Z-score < -2)	GR00366-A-117	9.96	KRAS TXN AFP
3	Decreased shRNA abundance (Z-score < -2)	GR00366-A-145	9.96	KRAS
4	Decreased shRNA abundance (Z-score < -2)	GR00366-A-165	9.96	KRAS
5	Decreased shRNA abundance (Z-score < -2)	GR00366-A-187	9.96	TXN
6	Decreased shRNA abundance (Z-score < -2)	GR00366-A-193	9.96	KRAS
7	Decreased shRNA abundance (Z-score < -2)	GR00366-A-204	9.96	TXN
8	Decreased shRNA abundance (Z-score < -2)	GR00366-A-216	9.96	KRAS
9	Decreased shRNA abundance (Z-score < -2)	GR00366-A-22	9.96	KRAS
10	Decreased shRNA abundance (Z-score < -2)	GR00366-A-27	9.96	KRAS
11	Decreased shRNA abundance (Z-score < -2)	GR00366-A-33	9.96	KRAS
12	Decreased shRNA abundance (Z-score < -2)	GR00366-A-48	9.96	AFP
13	Decreased shRNA abundance (Z-score < -2)	GR00366-A-53	9.96	KRAS
14	Decreased shRNA abundance (Z-score < -2)	GR00366-A-65	9.96	AFP
15	Decreased shRNA abundance (Z-score < -2)	GR00366-A-66	9.96	KRAS
16	Decreased shRNA abundance (Z-score < -2)	GR00366-A-75	9.96	TXN AFP
17	Decreased shRNA abundance (Z-score < -2)	GR00366-A-89	9.96	AFP
18	Reduced mammosphere formation	GR00396-S	9.1	GGT1 KMT2A KRAS MUC5AC AFP CHGA

Sources

Drugs & Therapeutics for Pancreatic Cystadenocarcinoma

Drugs for Pancreatic Cystadenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 10)

#

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Ethanol

Approved

Phase 1

64-17-5

702

Synonyms:

(C6-C9)Alkyl alcohol

[CH2Me(OH)]

[OEtH]

02483_FLUKA

02851_FLUKA

02853_FLUKA

02854_FLUKA

02855_FLUKA

02856_FLUKA

02856_SIAL

02857_FLUKA

02857_SIAL

02858_FLUKA

02858_SIAL

02860_FLUKA

02865_FLUKA

02865_SIAL

02870_FLUKA

02870_SIAL

02875_FLUKA

02877_FLUKA

02878_FLUKA

02882_FLUKA

02882_SIAL

02883_FLUKA

02884_FLUKA

02890_FLUKA

02890_SIAL

02891_FLUKA

02891_SIAL

100C.NPA

121182-78-3

187380_ALDRICH

187380_SIAL

1-Hydroxyethane

24102_RIEDEL

24102_SIAL

24103_RIEDEL

24103_SIAL

24105_RIEDEL

24105_SIAL

24106_RIEDEL

24106_SIAL

24194_RIEDEL

24194_SIAL

245119_ALDRICH

245119_SIAL

270741_ALDRICH

270741_SIAL

277649_ALDRICH

277649_SIAL

2858_SIGMA

29221_FLUKA

32205_RIEDEL

32205_SIAL

32221_RIEDEL

32221_SIAL

32294_RIEDEL

32294_SIAL

34870_SIAL

34963_RIEDEL

39278_FLUKA

40210_ALDRICH

40210_RIEDEL

41322_FLUKA

458600_ALDRICH

458600_SIAL

459828_ALDRICH

459828_SIAL

459836_ALDRICH

459836_SIAL

459844_SIAL

48075_SUPELCO

493511_SIAL

493538_ALDRICH

493538_SIAL

493546_ALDRICH

493546_SIAL

64-17-5

676829_SIAL

68475-56-9

71076-86-3

71329-38-9

8000-16-6

8024-45-1

absolute alcohol

Absolute alcohol

Absolute Alcohol

Absolute ethanol

Absolute Ethanol

Absolute ethyl alcohol

AC1L19TW

AC1Q31MM

Aethanol

Aethanol [German]

Aethylalkohol

AHD 2000

AI3-01706

Alcare hand degermer

Alcare Hand Degermer

alcohol

Alcohol

Alcohol (ethyl)

Alcohol (USP)

Alcohol [USP]

ALCOHOL 5% IN D5-W

Alcohol anhydrous

Alcohol Anhydrous

Alcohol dehydrated

Alcohol denatured

alcohol etilico

Alcohol etilico

Alcohol etílico

Alcohol, absolute

Alcohol, Absolute

Alcohol, anhydrous

Alcohol, dehydrated

Alcohol, Dehydrated

Alcohol, denatured

Alcohol, diluted

Alcohol, Diluted

Alcohol, ethyl

Alcohol, grain

Alcohol, Grain

Alcohols

Alcohols, C1-3

Alcohols, C30

Alcohols, C6-9

Alcool ethylique

Alcool Ethylique

Alcool éthylique

Alcool etilico

Alcool Etilico

Algrain

Alkohol

Alkohol [German]

Alkoholu etylowego

Alkoholu Etylowego

Aminoethanol

Anhydrol

Anhydrol PM 4085

Anhydrous alcohol

Anhydrous ethanol

Äthanol

Äthylalkohol

Beta-Aminoethanol

Beta-Aminoethyl Alcohol

Beta-Ethanolamine

Beta-Hydroxyethylamine

bmse000297

C00469

C2H5OH

C2H6O

Caswell No. 426

Caswell No. 430

CCRIS 945

CDA 19

CDA 19-200

CHEBI:16236

CHEMBL545

CID702

Colamine

Cologne spirit

Cologne Spirit

Cologne spirits

D000431

D00068

DB00898

Dehydrated alcohol

Dehydrated ethanol

Dehydrated Ethanol

Denatured alcohol

Denatured Alcohol

Denatured Alcohol Cd-10

Denatured Alcohol Cd-5

Denatured Alcohol Cd-5a

Denatured Alcohol Sd-1

Denatured Alcohol Sd-13a

Denatured Alcohol Sd-17

Denatured Alcohol Sd-23a

Denatured Alcohol Sd-28

Denatured Alcohol Sd-30

Denatured Alcohol Sd-39b

Denatured Alcohol Sd-39c

Denatured Alcohol Sd-3a

Denatured Alcohol Sd-40m

Denatured ethanol

Denatured Ethanol

Desinfektol el

Desinfektol EL

Diluted alcohol

Distilled spirits

E2385_SIGMA

E7023_ALDRICH

E7023_SIAL

E7148_ALDRICH

E7148_SIAL

E7517_SIGMA

EINECS 200-578-6

EINECS 270-649-4

Envision Conditioner Pdd 9020

EOH

EOX

Esumiru WK 88

ETA

etanol

Etanol

Etanolo

Etanolo [Italian]

ethanol

éthanol

Ethanol (9CI)

Ethanol [JAN]

Ethanol 200 proof

Ethanol 200 Proof

Ethanol Absolute

Ethanol Absolute Bp

Ethanol Anhydrous

Ethanol Extra Pure

Ethanol solution

Ethanol Vapor

Ethanol, Silent Spirit

Ethanol, undenatured

Ethanolum anhydricum

Ethicap

Ethyl alc

ethyl alcohol

Ethyl alcohol

Ethyl Alcohol

Ethyl Alcohol & Water, 10%

Ethyl Alcohol & Water, 20%

Ethyl Alcohol & Water, 30%

Ethyl Alcohol & Water, 40%

Ethyl Alcohol & Water, 5%

Ethyl Alcohol & Water, 50%

Ethyl Alcohol & Water, 60%

Ethyl Alcohol & Water, 70%

Ethyl Alcohol & Water, 80%

Ethyl Alcohol & Water, 95%

Ethyl Alcohol & Water, 96%

Ethyl alcohol anhydrous

Ethyl Alcohol Anhydrous

Ethyl alcohol in alcoholic beverages

Ethyl alcohol usp

Ethyl Alcohol, Anhydrous

Ethyl Alcohol, Denatured

Ethyl hydrate

Ethyl Hydrate

Ethyl hydroxide

Ethyl Hydroxide

Ethylalcohol

Ethylalcohol [Dutch]

Ethylol

Ethylolamine

Ethyloxy Group

EtOH

Etylowy alkohol

FEMA No. 2419

FEMA Number 2419

Fermentation alcohol

Glycinol

grain alcohol

Grain alcohol

Hinetoless

HSDB 531

HSDB 82

Hydroxyethane

HYDROXYETHYL GROUP

I14-12648

IMS 99

Infinity pure

Infinity Pure

Jaysol

Jaysol S

LS-1539

LTBB002977

Lux

Methylated spirit

Methylated Spirit Mineralised

Methylcarbinol

Molasses alcohol

MolPort-001-785-844

NCGC00091458-01

nchem.651-comp3c

nchembio.552-comp10

nchembio.94-comp20

NCI-C03134

NSC 85228

NSC85228

Oxydimethylene Group

potato Alcohol

Potato alcohol

Punctilious ethyl alcohol

Pyro

QMHAIh@

Reagent Alcohol

Ru-Tuss Expectorant

SDA 3A

SDA 40-2

SDM No. 37

Sekundasprit

Silent spirit

Spirit

Spirits of wine

Spirits OF wine

spiritus vini

Spiritus vini

Spirt

SY Fresh M

Synasol

Tecsol

Tecsol C

Thanol

Thiofaco M-50

Undenatured ethanol

UNII-3K9958V90M

USAF EK-1597

WLN: Q2

2

Paclitaxel

Approved, Vet_approved

Phase 1

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7 Epi taxol

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-epi-Paclitaxel

7-Epipaclitaxel

7-Epi-paclitaxel

7-epi-Taxol

7-Epitaxol

7-Epi-taxol

AB00513812

ABI 007

abi-007

ABI007

ABI-007

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

AC1L1IOG

AC1L1VJI

AC1L9AVF

AC-675

ACon1_002231

albumin-bound paclitaxel

Ambotz33069-62-4

ANX-513

Anzatax

Asotax

BIDD:PXR0046

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

Bris taxol

Bristaxol

BSPBio_000290

BSPBio_001152

BSPBio_002614

C07394

C466458

C47H51NO14

Capxol

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

cMAP_000068

CPD-8718

D00491

DB01229

DHP-107

DHP-208

DivK1c_000441

DRG-0190

DTS-301

Ebetaxel

EmPAC

Epitaxol

EU-0101201

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LipoPac

LMPR0104390001

Lopac0_001201

LS-31070

MBT 0206

MEGxp0_001940

Micellar Paclitaxel

Mitotax

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

MPI-5018

nab-paclitaxel

Nanotaxel

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

NCI60_000601

Neuro_000060

NINDS_000441

NK 105

Nova-12005

NP-010981

NSC 125973

NSC125973

NSC-125973

NSC358882

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

paclitaxel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paclitaxel, (4 alpha)-isomer

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S1150_Selleck

S-8184 Paclitaxel Injectable Emulsion

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

Spectrum_001536

SPECTRUM1503908

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

ST50306996

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TaxAlbin

Taxol

TAXOL

TAXOL (TN)

Taxol a

Taxol A

Taxol Konzentrat

TAXOL, 10-EPI,

Taxol, bris

Taxol.RTM. (Registered Trademark)

TXL

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

weekly paclitaxel

Xorane

Yewtaxan

3

Albumin-Bound Paclitaxel

Phase 1

4

Anti-Bacterial Agents

Phase 1

5

Antibiotics, Antitubercular

Phase 1

6

Anti-Infective Agents

Phase 1

7

Anti-Infective Agents, Local

Phase 1

8

Antimitotic Agents

Phase 1

9

Antineoplastic Agents, Phytogenic

Phase 1

10

Central Nervous System Depressants

Phase 1

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm	Terminated	NCT01525706	Phase 1	Ethanol and Paclitaxel Injection

Search NIH Clinical Center for Pancreatic Cystadenocarcinoma

Sources

Genetic Tests for Pancreatic Cystadenocarcinoma

Sources

Anatomical Context for Pancreatic Cystadenocarcinoma

MalaCards organs/tissues related to Pancreatic Cystadenocarcinoma:

⁴¹

Pancreas, Ovary, Liver, Kidney, Lymph Node

Sources

Publications for Pancreatic Cystadenocarcinoma

Articles related to Pancreatic Cystadenocarcinoma:

(show all 21)

#	Title	Authors	Year
1	Pancreatic pseudocyst or mucinous cystadenocarcinoma of pancreas? A diagnostic dilemma. ( 28396777 )	Joshi U....Basnet B.	2017
2	Serous cystadenocarcinoma of pancreas. ( 23763806 )	Rathore M.U....Umair B.	2013
3	Preoperative gemcitabine and oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma. ( 22949893 )	Di Marco M....Biasco G.	2012
4	Metastatic lymph node impostor in pancreatic cystadenocarcinoma. ( 15767737 )	Vu C.K....Meenan J.	2005
5	Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas. ( 11185714 )	Gagne L.J....Longnecker D.S.	2000
6	Pancreatitis associated with Crohn's disease: a premalignant state for cystadenocarcinoma of pancreas? ( 10445570 )	Gotian A....Katz S.	1999
7	Pancreatic cystadenocarcinoma in Peutz-Jeghers syndrome. ( 9412957 )	Pauwels M....Capron J.P.	1997
8	Association between pancreatic cystadenocarcinoma, malignant liver cysts, and polycystic disease of the kidney. ( 9178704 )	Niv Y....Fraser G.M.	1997
9	Needle aspiration cytology in the diagnosis of mucinous cystadenocarcinoma of pancreas. A study of five cases with an emphasis on utility and differential diagnosis. ( 7520925 )	Gupta R.K....alAnsari A.G.	1994
10	An alpha-fetoprotein producing pancreatic cystadenocarcinoma. ( 7522067 )	Kawamori T....Mori H.	1994
11	Comparison between a newly established pancreatic cystadenocarcinoma cell-line, ocup-1 and cells derived from pancreatic ductal carcinoma. ( 21567058 )	Chung Y....Sowa M.	1994
12	Immunohistochemical study of pancreatic cystadenocarcinoma. ( 1728123 )	Motojima K....Kanamatsu T.	1992
13	Pancreatic cystadenocarcinoma and pregnancy: a case report. ( 2368178 )	Baiocchi C....Ghislandi E.	1990
14	Two cases of pancreatic cystadenocarcinoma with elevated CA 19-9 levels in the cystic fluid in comparison with two cases of pancreatic cystadenoma. ( 2693299 )	Nishida K....Yoshikawa T.	1989
15	Unique appearance of the duodenal papilla in pancreatic cystadenocarcinoma. ( 2539985 )	Isaacs P.E.	1989
16	Pancreatic cystadenocarcinoma associated with strongyloides. ( 6741978 )	Setia U....Bhatia G.	1984
17	Zollinger-Ellison syndrome associated with pancreatic cystadenocarcinoma. ( 6493296 )	Margolis R.M....Jang N.	1984
18	Pancreatic cystadenocarcinoma--a diagnostic problem. ( 6850233 )	Andrew W.K.	1983
19	Pancreatic cystadenocarcinoma: diagnostic problems. ( 7116085 )	Busilacchi P....Zappasodi F.	1982
20	Pancreatic cystadenocarcinoma: CT body scan and gray scale ultrasound appearance. ( 98023 )	Carroll B....Sample W.F.	1978
21	A clinicopathologic study of 21 cases of pancreatic cystadenocarcinoma. ( 718294 )	Hodgkinson D.J....Weiland L.H.	1978

Sources

Genes for Pancreatic Cystadenocarcinoma

Genes related to Pancreatic Cystadenocarcinoma (0 elite genes):

(show all 17)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	CPQ	Carboxypeptidase Q	Protein Coding	15.45	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
2	MKI67	Marker Of Proliferation Ki-67	Protein Coding	14.92	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
3	KMT2A	Lysine Methyltransferase 2A	Protein Coding	14.58	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
4	SERPINA3	Serpin Family A Member 3	Protein Coding	14.27	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
5	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	13.9	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
6	PKDREJ	Polycystin Family Receptor For Egg Jelly	Protein Coding	13.88	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
7	CHGA	Chromogranin A	Protein Coding	13.77	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
8	SYP	Synaptophysin	Protein Coding	13.59	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
9	SERPINA1	Serpin Family A Member 1	Protein Coding	13.49	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
10	CALCA	Calcitonin Related Polypeptide Alpha	Protein Coding	13.27	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
11	AFP	Alpha Fetoprotein	Protein Coding	13.09	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
12	GLRX	Glutaredoxin	Protein Coding	5.5	DISEASES inferred ¹⁵
13	TXN	Thioredoxin	Protein Coding	4.38	DISEASES inferred ¹⁵
14	MUC5AC	Mucin 5AC, Oligomeric Mucus/Gel-Forming	Protein Coding	4.09	DISEASES inferred ¹⁵
15	GGT2	Gamma-Glutamyltransferase 2	Protein Coding	3.9	DISEASES inferred ¹⁵
16	GGT1	Gamma-Glutamyltransferase 1	Protein Coding	3.88	DISEASES inferred ¹⁵
17	CEACAM5	Carcinoembryonic Antigen Related Cell Adhesion Molecule 5	Protein Coding	3.04	DISEASES inferred ¹⁵

Sources

Variations for Pancreatic Cystadenocarcinoma

Sources

Expression for Pancreatic Cystadenocarcinoma

Search GEO for disease gene expression data for Pancreatic Cystadenocarcinoma.

Sources

Pathways for Pancreatic Cystadenocarcinoma

Pathways related to Pancreatic Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Folate Metabolism ¹ Show member pathways Selenium Micronutrient Network ¹ thioredoxin pathway ¹ Vitamin B12 Metabolism ¹	11.59	GGT1 GGT2 SERPINA3 TXN
2	NRF2 pathway ¹	11.09	GGT1 GGT2 SERPINA1 TXN
3	Eicosanoid Synthesis ¹	10.64	GGT1 GGT2
4	Aflatoxin activation and detoxification ⁶⁶	10.52	GGT1 GGT2

Sources

GO Terms for Pancreatic Cystadenocarcinoma

Cellular components related to Pancreatic Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular exosome	GO:0070062	9.81	CEACAM5 CPQ GGT1 GGT2 GLRX MUC5AC
2	extracellular space	GO:0005615	9.56	AFP CALCA CHGA CPQ GGT1 MUC5AC
3	extracellular region	GO:0005576	9.28	AFP CALCA CEACAM5 CHGA CPQ MUC5AC

Biological processes related to Pancreatic Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	regulation of long-term neuronal synaptic plasticity	GO:0048169	9.37	KRAS SYP
2	zymogen activation	GO:0031638	9.32	GGT1 GGT2
3	regulation of short-term neuronal synaptic plasticity	GO:0048172	9.26	KMT2A SYP
4	positive regulation of cAMP metabolic process	GO:0030816	9.16	CALCA CHGA
5	glutathione catabolic process	GO:0006751	8.96	GGT1 GGT2
6	leukotriene D4 biosynthetic process	GO:1901750	8.62	GGT1 GGT2

Molecular functions related to Pancreatic Cystadenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	glutathione hydrolase activity	GO:0036374	8.62	GGT1 GGT2

Sources

Sources for Pancreatic Cystadenocarcinoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia